About Us Menu

• Management Team
• Board of Directors
• Medical and Scientific Advisors
• Business Development
• Collaborations
• Careers
• Contact Us

Main Menu

• Home
• About Us
  • Management Team
  • Board of Directors
  • Medical and Scientific Advisors
  • Business Development
  • Intellectual Property
  • Collaborations
  • Careers
  • Contact Us
• Oncology
  • Pipeline
  • Clinical Programs
    • Bavituximab
    • Cotara®
  • Technology Overview
    • Bavituximab
    • Cotara®
  • Preclinical Programs
    • Anti-Angiogenesis Agents
    • Vascular Targeting Agents (VTAs)
• Infectious Diseases
  • PS Technology Overview
    • Biodefense
    • HCV Clinical Program
    • Virus Infection Therapy
    • Topical Microbicides
    • Vaccine Adjuvants
    • Protozoan Parasitic Infections
  • Pipeline
  • Mechanism of Action
  • Bavituximab HCV Clinical Program
  • TMTI Government Contract
• Contract Manufacturing
• Investors
  • Investor FAQs
  • Contact Us
  • Stock Quote & Chart
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • News Releases
  • Annual Reports
  • Event Calendar
  • E-mail Alerts
• News & Resources
  • Fact Sheets
  • News Releases
  • Upcoming Events
  • Media Contact

Clinical Menu

• Bavituximab
• Cotara®
• Investigator Sponsored Trial Program
• Peregrine Bavituximab and Cotara Clinical Trials

• Clinical Pipeline Chart
• Clinical Programs